Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs can’t do? While a medicine that reverses the clock would be a ...

An estimated 1.5 million Britons are now using wonder drugs such as Ozempic, Mounjaro or Wegovy. But new research suggests it ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

India is among the top two countries in terms of type 2 diabetes cases and third in terms of obesity; hence, the need for ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...